Literature DB >> 24097340

Levobupivacaine vs. bupivacaine for third molar surgery: quality of anaesthesia, postoperative analgesia and local vascular effects.

Denis Brajkovic1, Bozidar Brkovic, Marija Milic, Vladimir Biocanin, Elena Krsljak, Dragica Stojic.   

Abstract

OBJECTIVES: The main purpose of this prospective, double-blind, randomized study was to evaluate anaesthetic parameters, postoperative analgesia and vasoactive properties of levobupivacaine and bupivacaine for lower third molar surgery.
MATERIAL AND METHODS: Sixty patients (ASA I) were scheduled for lower third molar surgery under inferior alveolar nerve block, lingual nerve block and buccal nerve block (mandibular nerve blocks) obtained with 3 ml of 0.5 % levobupivacaine and 3 ml of 0.5 % bupivacaine. Success rate, onset and duration of three nerve bocks were evaluated by electrical pulp testing, pinprick testing and signs of soft tissue anaesthesia (patient-reported numbness). Intensity of intraoperative anaesthesia and postoperative analgesia were measured with visual analogue scale (VAS) and numeric rating scale (NRS). The time of first postoperative pain reported and analgesic consumption were also recorded. The laser Doppler flowmetry was used for the measurement of the first premolar pulpal blood flow.
RESULTS: There were no differences between levobupivacaine and bupivacaine regarding the success rate, onset and duration of mandibular nerve blocks as well as intensity of postoperative analgesia and analgesic consumption. Intensity of intraoperative anaesthesia and duration of postoperative analgesia were significantly higher in the levobupivacaine than in the bupivacaine group. Both anaesthetics showed similar biphasic vasoactive effect.
CONCLUSIONS: Levobupivacaine 0.5 % achieved superiority over bupivacaine 0.5 % in the intensity of intraoperative anaesthesia and duration of postoperative analgesia for lower third molar surgery under the mandibular nerve blocks. CLINICAL RELEVANCE: It seems that the plain levobupivacaine (0.5 %) could be an effective alternative to plain bupivacaine (0.5 %) in those dental procedures which require profound bone and soft tissue anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24097340     DOI: 10.1007/s00784-013-1114-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  28 in total

1.  Correction factor for comparisons between levobupivacaine and racemic bupivacaine.

Authors:  S A Schug
Journal:  Reg Anesth Pain Med       Date:  2001 Jan-Feb       Impact factor: 6.288

Review 2.  Developments in local anaesthetic drugs.

Authors:  J B Whiteside; J A Wildsmith
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

3.  Safety and efficacy of levobupivacaine for postoperative pain relief after the surgical removal of impacted third molars: a comparison with lignocaine and adrenaline.

Authors:  J P Rood; P Coulthard; A T Snowdon; B A Gennery
Journal:  Br J Oral Maxillofac Surg       Date:  2002-12       Impact factor: 1.651

4.  The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients.

Authors:  Lucia Gagliese; Nataly Weizblit; Wendy Ellis; Vincent W S Chan
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

Review 5.  Bupivacaine, levobupivacaine and ropivacaine: are they clinically different?

Authors:  Andrea Casati; Marta Putzu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2005-06

6.  Lipophilicity but not stereospecificity is a major determinant of local anaesthetic-induced cytotoxicity in human T-lymphoma cells.

Authors:  Robert Werdehausen; Sebastian Braun; Sepideh Fazeli; Henning Hermanns; Markus W Hollmann; Inge Bauer; Markus F Stevens
Journal:  Eur J Anaesthesiol       Date:  2012-01       Impact factor: 4.330

7.  A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers.

Authors:  H Bardsley; R Gristwood; H Baker; N Watson; W Nimmo
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

8.  A comparison of bupivacaine to lidocaine with respect to duration in the maxilla and mandible.

Authors:  P E Teplitsky; C A Hablichek; J S Kushneriuk
Journal:  J Can Dent Assoc       Date:  1987-06       Impact factor: 1.316

9.  A prospective, randomized, double-blinded comparison between multimodal thoracic paravertebral bupivacaine and levobupivacaine analgesia in patients undergoing lung surgery.

Authors:  Vesna Novak-Jankovic; Zoka Milan; Iztok Potocnik; Tomaz Stupnik; Stela Maric; Tatjana Stopar-Pintaric; Boriana Kremzar
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-04-05       Impact factor: 2.628

Review 10.  Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine.

Authors:  Stefania Leone; Simone Di Cianni; Andrea Casati; Guido Fanelli
Journal:  Acta Biomed       Date:  2008-08
View more
  4 in total

1.  Bone microRNA-21 as surgical stress parameter is associated with third molar postoperative discomfort.

Authors:  Milan Vucetic; Jelena Roganovic; Martin Freilich; David Shafer; Marija Milic; Ljiljana DJukic; Nina Petrovic; Evgenija Markovic; Aleksa Markovic; Bozidar Brkovic
Journal:  Clin Oral Investig       Date:  2020-06-04       Impact factor: 3.573

2.  Local anaesthesia for surgical extraction of mandibular third molars: a systematic review and network meta-analysis.

Authors:  Fan Yang; Yuxuan Gao; Lan Zhang; Bo Zheng; Liu Wang; Huan Sun; Dingming Huang
Journal:  Clin Oral Investig       Date:  2020-08-24       Impact factor: 3.573

3.  Efficacy and safety of 1% ropivacaine for postoperative analgesia after lower third molar surgery: a prospective, randomized, double-blinded clinical study.

Authors:  Božidar Brković; Miroslav Andrić; Dejan Ćalasan; Marija Milić; Jelena Stepić; Milan Vučetić; Denis Brajković; Ljubomir Todorović
Journal:  Clin Oral Investig       Date:  2016-04-25       Impact factor: 3.573

4.  Effectiveness of anesthetic solutions for pain control in lower third molar extraction surgeries: a systematic review of randomized clinical trials with network meta-analysis.

Authors:  Marco Tulio Rossi; Murilo Navarro de Oliveira; Maria Tereza Campos Vidigal; Walbert de Andrade Vieira; Cristiano Elias Figueiredo; Cauane Blumenberg; Vinicius Lima de Almeida; Luiz Renato Paranhos; Luciana Butini Oliveira; Walter Luiz Siqueira; Rui Barbosa de Brito Júnior
Journal:  Clin Oral Investig       Date:  2020-11-08       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.